BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25799154)

  • 1. Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer.
    Ajona D; Razquin C; Pastor MD; Pajares MJ; Garcia J; Cardenal F; Fleischhacker M; Lozano MD; Zulueta JJ; Schmidt B; Nadal E; Paz-Ares L; Montuenga LM; Pio R
    PLoS One; 2015; 10(3):e0119878. PubMed ID: 25799154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.
    Ajona D; Pajares MJ; Corrales L; Perez-Gracia JL; Agorreta J; Lozano MD; Torre W; Massion PP; de-Torres JP; Jantus-Lewintre E; Camps C; Zulueta JJ; Montuenga LM; Pio R
    J Natl Cancer Inst; 2013 Sep; 105(18):1385-93. PubMed ID: 23940286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
    Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
    J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma.
    Ajona D; Pajares MJ; Chiara MD; Rodrigo JP; Jantus-Lewintre E; Camps C; Suarez C; Bagán JV; Montuenga LM; Pio R
    Oral Dis; 2015 Oct; 21(7):899-904. PubMed ID: 26258989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free Airway C4d after Lung Transplantation - A Quantitative Analysis of Bronchoalveolar Lavage Fluid.
    Heigl T; Saez-Gimenez B; Van Herck A; Kaes J; Sacreas A; Beeckmans H; Ambrocio GPL; Kwakkel-Van Erp H; Ordies S; Vanstapel A; Verleden SE; Neyrinck AP; Ceulemans LJ; Van Raemdonck DE; Verbeken E; Verleden GM; Vos R; Vanaudenaerde B
    Transpl Immunol; 2021 Feb; 64():101352. PubMed ID: 33217540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased level of annexin A1 in bronchoalveolar lavage fluid as a potential diagnostic indicator for lung cancer.
    Biaoxue R; Xiguang C; Hua L; Tian F; Wenlong G
    Int J Biol Markers; 2017 Mar; 32(1):e132-e140. PubMed ID: 28009433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of protein markers in combination with ThinPrep bronchial brush cytology in classification of lung cancer subtypes].
    Yang Y; Pan QJ; Teng MF; Li ZL; Zhao LL; Han NJ; Gao YN; Cao J
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):616-9. PubMed ID: 19102942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of VEGF and sVEGFR-1 in bronchoalveolar lavage fluid for differential diagnosis of primary lung cancer.
    Cao C; Sun SF; Lv D; Chen ZB; Ding QL; Deng ZC
    Asian Pac J Cancer Prev; 2013; 14(4):2443-6. PubMed ID: 23725155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular Endothelial Growth Factor-D (VEGF-D) is Elevated in Bronchoalveolar Lavage Fluid of Patients with Lung Squamous Carcinoma.
    Lv D; Tan L; Zhang Q; Ma H; Zhang Y; Zhang Q; Yu Y; Chen Z; Ding Q; Deng Z
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte-bound complement activation products as biomarkers for diagnosis of systemic lupus erythematosus.
    Liu CC; Kao AH; Hawkins DM; Manzi S; Sattar A; Wilson N; Ahearn JM
    Clin Transl Sci; 2009 Aug; 2(4):300-8. PubMed ID: 20161444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus.
    Li J; An L; Zhang Z
    Clin Exp Rheumatol; 2014; 32(1):48-53. PubMed ID: 23981509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of Expression of Complement C4d in Esophageal Squamous Cell Carcinoma.
    Kikuchi M; Nakajima M; Muroi H; Takahashi M; Itoh J; Yamaguchi S; Sasaki K; Kato H
    Anticancer Res; 2016 Sep; 36(9):4553-7. PubMed ID: 27630295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchoalveolar Lavage Proteomics in Patients with Suspected Lung Cancer.
    Carvalho AS; Cuco CM; Lavareda C; Miguel F; Ventura M; Almeida S; Pinto P; de Abreu TT; Rodrigues LV; Seixas S; Bárbara C; Azkargorta M; Elortza F; Semedo J; Field JK; Mota L; Matthiesen R
    Sci Rep; 2017 Feb; 7():42190. PubMed ID: 28169345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of diagnostic value of four tumor markers in bronchoalveolar lavage fluid of peripheral lung cancer.
    Li J; Chen P; Mao CM; Tang XP; Zhu LR
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):141-8. PubMed ID: 23551358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic usefulness of selected tumor markers (CA125, CEA, CYFRA 21-1) in bronchoalveolar lavage fluid in patients with non-small cell lung cancer].
    Dabrowska M; Grubek-Jaworska H; Domagała-Kulawik J; Bartoszewicz Z; Kondracka A; Krenke R; Nejman P; Chazan R
    Pol Arch Med Wewn; 2004 Jun; 111(6):659-65. PubMed ID: 15508787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratin tumor marker levels in bronchial washing in the diagnosis of lung cancer.
    Trevisani L; Putinati S; Sartori S; Abbasciano V; Bagni B
    Chest; 1996 Jan; 109(1):104-8. PubMed ID: 8549168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer.
    Korkmaz ET; Koksal D; Aksu F; Dikmen ZG; Icen D; Maden E; Onder S; Akbiyik F; Emri S
    Clin Biochem; 2018 Aug; 58():15-19. PubMed ID: 29729229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-human leukocyte antigen antibodies, vascular C4d deposition and increased soluble c4d in broncho-alveolar lavage of lung allografts.
    Girnita AL; Lee TM; McCurry KR; Baldwin WM; Yousem SA; Detrick B; Pilewski J; Toyoda Y; Jelinek L; Lomago J; Zaldonis D; Spichty KJ; Zeevi A
    Transplantation; 2008 Jul; 86(2):342-7. PubMed ID: 18645500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compensated Interferometry Measures of CYFRA 21-1 Improve Diagnosis of Lung Cancer.
    Kammer MN; Kussrow AK; Webster RL; Chen H; Hoeksema M; Christenson R; Massion PP; Bornhop DJ
    ACS Comb Sci; 2019 Jun; 21(6):465-472. PubMed ID: 31022347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of MAGE A1-6 RT-nested PCR for diagnosis of lung cancer invisible by bronchoscopy.
    Shin KC; Choi EY; Chung JH; Jeon C; Lee KH
    Anticancer Res; 2012 Jan; 32(1):163-7. PubMed ID: 22213302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.